Kinetyx’ director, Robin Thurston, believes that every shoe in the world will be fitted with sensors twenty years from now. The Canadian high-tech company, which was spun off by its parent, Orpyx Medical Technologies, nearly one year ago, has secured new funding for its continued R&D on a “kinesomic sensory insole” and the supporting software.

The kinesome is described as a constellation of data collected through pressure sensors to show how a person moves and to enable “athletic longevity.” The first offerings, Kinetyx Lab and Kinetyx Pro, are due to enter the market later this year. The $3.1 million Seed Series investment round was led by Next Ventures, accompanied by Paddock Capital, Thja Ventures and other investors.